Venture capital firm Sequoia Capital China has led the $50-million Series C fundraising round in Adagene, a Chinese antibody discovery and development firm based in Suzhou, according to an announcement.
Continue reading this premium story with a subscription to DealStreetAsia.
SubscribeAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com